Rachel E. Gershman

2.6k total citations
3 papers, 332 citations indexed

About

Rachel E. Gershman is a scholar working on Oncology, Cell Biology and Organic Chemistry. According to data from OpenAlex, Rachel E. Gershman has authored 3 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 2 papers in Cell Biology and 1 paper in Organic Chemistry. Recurrent topics in Rachel E. Gershman's work include Cancer-related Molecular Pathways (2 papers), Microtubule and mitosis dynamics (2 papers) and Neuroblastoma Research and Treatments (1 paper). Rachel E. Gershman is often cited by papers focused on Cancer-related Molecular Pathways (2 papers), Microtubule and mitosis dynamics (2 papers) and Neuroblastoma Research and Treatments (1 paper). Rachel E. Gershman collaborates with scholars based in United States. Rachel E. Gershman's co-authors include Kara M. Hoar, Mark Manfredi, Stephen G. Stroud, Deborah R. Wysong, David A. Janowick, Christopher F. Claiborne, Jeffrey Ecsedy, Todd B. Sells, Patrick Leroy and Joseph B. Bolen and has published in prestigious journals such as Clinical Cancer Research, Bioorganic & Medicinal Chemistry Letters and ACS Medicinal Chemistry Letters.

In The Last Decade

Rachel E. Gershman

3 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel E. Gershman United States 3 221 190 171 51 35 3 332
Victoria Lock United Kingdom 9 126 0.6× 207 1.1× 187 1.1× 40 0.8× 43 1.2× 11 353
Gabriel S. Weatherhead United States 3 351 1.6× 331 1.7× 263 1.5× 55 1.1× 23 0.7× 3 474
Fiona Girdler United Kingdom 7 346 1.6× 327 1.7× 288 1.7× 42 0.8× 15 0.4× 7 475
Adelaida Piera Spain 5 94 0.4× 229 1.2× 107 0.6× 35 0.7× 16 0.5× 7 336
Anqun Tang China 5 137 0.6× 243 1.3× 143 0.8× 21 0.4× 11 0.3× 6 361
Keyu Gao China 7 155 0.7× 239 1.3× 136 0.8× 20 0.4× 18 0.5× 11 385
Caroline Topham United Kingdom 7 178 0.8× 277 1.5× 146 0.9× 13 0.3× 21 0.6× 9 361
Nandini Sakurikar United States 8 100 0.5× 236 1.2× 136 0.8× 13 0.3× 29 0.8× 10 337
Fanmao Zhang United States 6 148 0.7× 270 1.4× 181 1.1× 14 0.3× 22 0.6× 8 421
Matthias Reule United Kingdom 6 69 0.3× 167 0.9× 103 0.6× 14 0.3× 22 0.6× 11 273

Countries citing papers authored by Rachel E. Gershman

Since Specialization
Citations

This map shows the geographic impact of Rachel E. Gershman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Gershman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Gershman more than expected).

Fields of papers citing papers by Rachel E. Gershman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Gershman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Gershman. The network helps show where Rachel E. Gershman may publish in the future.

Co-authorship network of co-authors of Rachel E. Gershman

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Gershman. A scholar is included among the top collaborators of Rachel E. Gershman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Gershman. Rachel E. Gershman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Sells, Todd B., Ryan Chau, Jeffrey Ecsedy, et al.. (2015). MLN8054 and Alisertib (MLN8237): Discovery of Selective Oral Aurora A Inhibitors. ACS Medicinal Chemistry Letters. 6(6). 630–634. 83 indexed citations
2.
Haddad, Terra D., et al.. (2012). Synthesis and evaluation of 4-(substituted styryl/alkenyl)-3,5-bis(4-hydroxyphenyl)-isoxazoles as ligands for the estrogen receptor. Bioorganic & Medicinal Chemistry Letters. 22(18). 5999–6003. 7 indexed citations
3.
Manfredi, Mark, Jeffrey Ecsedy, Arijit Chakravarty, et al.. (2011). Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays. Clinical Cancer Research. 17(24). 7614–7624. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Victoria Lock Breakdown of academic impact, for papers by Gabriel S. Weatherhead Breakdown of academic impact, for papers by Fiona Girdler Breakdown of academic impact, for papers by Adelaida Piera Breakdown of academic impact, for papers by Anqun Tang Breakdown of academic impact, for papers by Keyu Gao Breakdown of academic impact, for papers by Caroline Topham Breakdown of academic impact, for papers by Nandini Sakurikar Breakdown of academic impact, for papers by Fanmao Zhang Breakdown of academic impact, for papers by Matthias Reule
Rankless by CCL
2026